Literature DB >> 23747880

The role of TLR4 in the pathogenesis of indirect acute lung injury.

Rong Hu1, Hui Xu, Hong Jiang, Ying Zhang, Yu Sun.   

Abstract

Indirect acute lung injury (IALI) manifests as rapid-onset respiratory failure following secondary clinical events to the parenchyma or lung vasculature, such as hemorrhage shock, extra-pulmonary sepsis, trauma, ischemia-reperfusion, and burn injury. Accumulating evidence demonstrates the pivotal role of pattern recognition receptors (PRRs) in the innate immune system of lung diseases. Toll like receptor 4 (TLR4), one of the well characterized PRRs, recognizes not only the lipopolysaccharide (LPS) of Gram-negative bacteria, but also the endogenous ligands in IALI. In this review, we summarize a variety of reports concerning the role of TLR4 and IALI pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23747880     DOI: 10.2741/4176

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  17 in total

1.  Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.

Authors:  Guang Feng; Ze-Yu Jiang; Bo Sun; Jie Fu; Tian-Zuo Li
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Pulmonary endothelial protein kinase C-delta (PKCδ) regulates neutrophil migration in acute lung inflammation.

Authors:  Mark J Mondrinos; Ting Zhang; Shuang Sun; Paul A Kennedy; Devon J King; Marla R Wolfson; Linda C Knight; Rosario Scalia; Laurie E Kilpatrick
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

3.  The development of early-onset ventilator-associated pneumonia after cardiac surgery with cardiopulmonary bypass is associated with toll-like receptor 4 signal transduction pathways.

Authors:  Xiang Liu; Yanhu Wu; Yihu Tang; Zhi Geng; Yaping Han; Dongyue Zhang
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Experimental Study of the Protective Effect of Simvastatin on Lung Injury in Rats with Sepsis.

Authors:  Yu Wang; Wenping Yang; Xin Zhao; Rong Zhang
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

5.  Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19.

Authors:  Pradeep Singh Cheema; Deeptashree Nandi; Alo Nag
Journal:  Open Biol       Date:  2021-06-09       Impact factor: 6.411

6.  Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.

Authors:  Xinjin Chi; Xiaoxia Wei; Wanling Gao; Jianqiang Guan; Xiaofan Yu; Yiheng Wang; Xi Li; Jun Cai
Journal:  J Transl Med       Date:  2015-06-13       Impact factor: 5.531

7.  MiR-30a targets IL-1α and regulates islet functions as an inflammation buffer and response factor.

Authors:  Xin Jiang; Chenke Xu; Fan Lei; Meijian Liao; Wei Wang; Naihan Xu; Yaou Zhang; Weidong Xie
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

8.  Early and late pulmonary effects of nebulized LPS in mice: An acute lung injury model.

Authors:  Natália de Souza Xavier Costa; Gabriel Ribeiro Júnior; Adair Aparecida Dos Santos Alemany; Luciano Belotti; Douglas Hidalgo Zati; Marcela Frota Cavalcante; Mariana Matera Veras; Susan Ribeiro; Esper Georges Kallás; Paulo Hilário Nascimento Saldiva; Marisa Dolhnikoff; Luiz Fernando Ferraz da Silva
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

9.  The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model.

Authors:  Stephen Wedgwood; Cris Warford; Sharleen R Agvatisiri; Phung N Thai; Nipavan Chiamvimonvat; Karen M Kalanetra; Satyan Lakshminrusimha; Robin H Steinhorn; David A Mills; Mark A Underwood
Journal:  Pediatr Res       Date:  2019-09-19       Impact factor: 3.756

10.  Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis.

Authors:  Stephen Wedgwood; Kimberly Gerard; Katrina Halloran; Ashley Hanhauser; Sveva Monacelli; Cris Warford; Phung N Thai; Nipavan Chiamvimonvat; Satyan Lakshminrusimha; Robin H Steinhorn; Mark A Underwood
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.